Catabasis names Rick Modi chief business officer
This article was originally published in Scrip
Executive Summary
Catabasis Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapeutics using its SMART linker technology platform, has named Rick Modi chief business officer. Prior to joining Catabasis, Mr Modi was senior vice-president, global marketing at InterMune, an orphan drug company that was acquired by Roche in 2014.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.